Jeffrey A Bluestone

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Regulatory T Cells

Immune Response

Endoplasmic Reticulum Stress

Top Venues

Science translational medicine

Journal of immunology (Baltimore, Md. : 1950)

Science immunology

Nature biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Patrick Ho, Ellen Cahir-McFarland, Jason D Fontenot, Tracey Lodie, Adel Nada, Qizhi Tang, Laurence A Turka, Jeffrey A Bluestone
Harnessing regulatory T cells to establish immune tolerance. Science translational medicine 16 (738) (2024)
Patrick Ho, Ellen Cahir-McFarland, Jason D Fontenot, Tracey Lodie, Adel Nada, Qizhi Tang, Laurence A Turka, Jeffrey A Bluestone
Harnessing regulatory T cells to establish immune tolerance. Science translational medicine 16 (738) (2024)
Daniel B Goodman, Camillia S Azimi, Kendall Kearns, Alexis Talbot, Kiavash Garakani, Julie M Garcia, Nisarg A Patel, Byungjin Hwang, David S Lee, Minhee Park, Vivasvan S Vykunta, Brian R Shy, Chun Jimmie Ye, Justin Eyquem, Alexander Marson, Jeffrey A Bluestone, Kole T Roybal
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies. Science translational medicine 14 (670) (2022)
James C Lee, Sadaf Mehdizadeh, Jennifer A Smith, Arabella Young, Ilgiz A Mufazalov, Cody T Mowery, Adil I Daud, Jeffrey A Bluestone
Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis. Science immunology 5 (52) (2021)
Jeffrey A Bluestone, Jane H Buckner, Kevan C Herold
Immunotherapy: Building a bridge to a cure for type 1 diabetes. Science (New York, N.Y.) 373 (6554) (2021)
Kathrin Schumann, Siddharth S Raju, Michael Lauber, Saskia Kolb, Eric Shifrut, Jessica T Cortez, Nikolaos Skartsis, Vinh Q Nguyen, Jonathan M Woo, Theodore L Roth, Ruby Yu, Michelle L T Nguyen, Dimitre R Simeonov, David N Nguyen, Sasha Targ, Rachel E Gate, Qizhi Tang, Jeffrey A Bluestone, Matthew H Spitzer, Chun Jimmie Ye, Alexander Marson
Functional CRISPR dissection of gene networks controlling human regulatory T cell identity. Nature immunology 21 (11) (2020)
Ilgiz A Mufazalov, David Andruszewski, Carsten Schelmbauer, Sylvia Heink, Michaela Blanfeld, Joumana Masri, Yilang Tang, Rebecca Schüler, Christina Eich, F Thomas Wunderlich, Susanne Helena Karbach, Jeffrey A Bluestone, Thomas Korn, Esther Von Stebut
Cutting Edge: IL-6-Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression. Journal of immunology (Baltimore, Md. : 1950) 204 (4) (2020)
Jessica T Cortez, Elena Montauti, Eric Shifrut, Jovylyn Gatchalian, Yusi Zhang, Oren Shaked, Yuanming Xu, Theodore L Roth, Dimitre R Simeonov, Yana Zhang, Siqi Chen, Zhongmei Li, Jonathan M Woo, Josephine Ho, Ian A Vogel, Grace Y Prator, Bin Zhang, Youjin Lee, Zhaolin Sun, Igal Ifergan, Frédéric Van Gool, Diana C Hargreaves, Jeffrey A Bluestone, Alexander Marson, Deyu Fang
CRISPR screen in regulatory T cells reveals modulators of Foxp3. Nature 582 (7812) (2020)
Daniel R Holohan, Frédéric Van Gool, Jeffrey A Bluestone
Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model. PloS one 14 (10) (2019)
Abul K Abbas, Eleonora Trotta, Dimitre R Simeonov, Alexander Marson, Jeffrey A Bluestone
Revisiting IL-2: Biology and therapeutic prospects. Science immunology 3 (25) (2019)
David N Nguyen, Theodore L Roth, P Jonathan Li, Peixin Amy Chen, Ryan Apathy, Murad R Mamedov, Linda T Vo, Victoria R Tobin, Daniel Goodman, Eric Shifrut, Jeffrey A Bluestone, Jennifer M Puck, Francis C Szoka, Alexander Marson
Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency. Nature biotechnology 38 (1) (2019)
Caroline Raffin, Linda T Vo, Jeffrey A Bluestone
Treg cell-based therapies: challenges and perspectives. Nature reviews. Immunology 20 (3) (2019)
Leonardo M R Ferreira, Yannick D Muller, Jeffrey A Bluestone, Qizhi Tang
Next-generation regulatory T cell therapy. Nature reviews. Drug discovery 18 (10) (2019)
Jamie B Spangler, Eleonora Trotta, Jakub Tomala, Ariana Peck, Tracy A Young, Christina S Savvides, Stephanie Silveria, Petra Votavova, Joshua Salafsky, Vijay S Pande, Marek Kovar, Jeffrey A Bluestone, K Christopher Garcia
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy. Journal of immunology (Baltimore, Md. : 1950) 201 (7) (2018)
Jeffrey A Bluestone
FOXP3, the Transcription Factor at the Heart of the Rebirth of Immune Tolerance. Journal of immunology (Baltimore, Md. : 1950) 198 (3) (2018)